Synergy Pharma constipation drug succeeds mid-stage trial

November 19, 2014 2:17 PM

2 0

Synergy Pharmaceuticals shares were up 8 percent in premarket trading.

The drug SP-333 showed statistically significant improvement in spontaneous bowel movement in the fourth week of treatment, compared with a placebo, the company said on Wednesday.

Read more

To category page